Use Of Patented Traditional Chinese Medicine Against Covid-19 : : A Practical Manual.
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | Singapore : : World Scientific Publishing Company,, 2021. Ã2021. |
Year of Publication: | 2021 |
Edition: | 1st ed. |
Language: | English |
Online Access: | |
Physical Description: | 1 online resource (187 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Intro
- Contents
- Preface
- About the Editors-in-Chief
- Editorial Board
- Chapter 1 Understanding COVID-19
- Section 1: Understanding of COVID-19 in Modern Medicine
- I. Basic Facts
- 1. Terminology
- 2. Pathogenic characteristics
- II. Epidemiological Characteristics
- 1. Source of infection
- 2. Transmission route
- 3. Susceptible population
- III. Clinical Features
- 1. Clinical manifestations
- 2. Auxiliary tests
- 3. Diagnostic criteria
- 3.1. Suspected cases
- 3.2. Confirmed cases
- 3.3. Standardized ICD code
- 4. Clinical classification
- 4.1. Mild cases
- 4.2. Common cases
- 4.3. Severe cases
- 4.4. Critical cases
- 5. Differential diagnosis
- Section 2: Understanding COVID-19 in Traditional Chinese Medicine
- I. Historical Review
- II. Disease Name
- III. Etiology and Pathogenesis
- IV. Treatment by Stages
- Chapter 2 Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia
- I. Etiological Characteristics
- II. Epidemiological Characteristics
- 1. Source of infection
- 2. Route of transmission
- 3. Susceptible population
- III. Pathological Changes
- 1. Lungs
- 2. Spleen, hilar lymph nodes, and bone marrow
- 3. Heart and blood vessels
- 4. Liver and gallbladder
- 5. Kidneys
- 6. Other organs
- IV. Clinical Characteristics
- 1. Clinical manifestations
- 2. Laboratory tests
- 2.1. General findings
- 2.2. Pathogenic and serological findings
- 3. Chest imaging
- V. Case Definitions
- 1. Suspected cases
- 1.1. Epidemiological history
- 1.2. Clinical manifestations
- 2. Confirmed cases
- VI. Clinical Classification
- 1. Mild cases
- 3. Severe adult cases meeting any of the following criteria
- 4. Critical cases
- VII. Early Clinical Warning Indicators of Severe and Critical Cases
- 1. Adults
- 2. Children
- VIII. Differential Diagnosis
- IX. Case Finding and Reporting.
- X. Treatment
- 1. Treatment venue determined by the severity of the disease
- 2. General treatment
- 3. Treatment of severe and critical cases
- 3.1. Treatment principle
- 3.2. Respiratory support
- 3.3. Circulatory support
- 3.4. Renal failure and renal replacement therapy
- 3.5. Convalescent plasma treatment
- 3.6. Blood purification treatment
- 3.7. Immunotherapy
- 3.8. Other therapeutic measures
- 4. Traditional Chinese medicine treatment
- 4.1. During medical observation
- 4.2. During clinical treatment (confirmed cases)
- XI. Discharge Criteria and After-Discharge Considerations
- 1. Discharge criteria
- 2. After-discharge considerations
- XII. Patients Transportation Principles
- XIII. Nosocomial Infection Prevention and Control
- Chapter 3 Rational Use of Chinese Patent Medicine
- Section 1: Guiding Principles for the Clinical Application of Chinese Patent Medicine
- I. Safety of Chinese Patent Medicine
- II. Basic Principles of Clinical Application of Chinese Patent Medicine
- 1. Use medicines based on pattern diagnosis/syndrome differentiation
- 2. Medication selection based on both disease and pattern diagnosis
- 3. Selection of dosage form
- 4. Determination of dosage
- 5. Rational administration route
- 6. The use of Chinese medicine injection should also follow the below principles
- III. Principle for Combined Use
- 1. Combined use of Chinese patent medicines
- 2. Combined use of Chinese patent medicine and Western medicine
- IV. Principles of Use of Chinese Patent Medicine for Pregnant Women
- V. Principles for the Use of Chinese Patent Medicine Among Children
- Section 2: Contraindications in the Use of Chinese Patent Medicine
- I. Contraindicated Patterns/Syndromes
- II. Contraindicated Combination (Incompatibility)
- III. Contraindications During Pregnancy
- IV. Contraindications in Diet.
- Section 3: Adverse Reactions and Adverse Events of Chinese Patent Medicine
- I. Factors Causing ADRs/ADEs of Chinese Patent Medicine
- 1. Medicines
- 1.1. The ingredients of traditional Chinese medicines
- 1.2. Misuse and Misapplication
- 1.3. Quality of medicinal substances
- 1.4. Improper processing or manufacturing
- 1.5. Non-standard package insert
- 2. Patients
- 2.1. Special populations
- 2.2. Idiosyncrasy
- 3. Clinical use
- 3.1. Inaccurate pattern diagnosis
- 3.2. Overdose and prolonged use
- 3.3. Improper combination
- II. Management of ADRs/ADEs of Chinese Patent Medicines
- 1. Right medicines for the right pattern
- 2. Knowing about the Chinese patent medicine before use
- 3. Treatment in accordance with season, region, and patient
- 4. Rational concomitant medications
- 5. Proper dosage &
- dosage forms
- Chapter 4 Guidance on Rational Application of Chinese Patent Medicine during Medical Observation Period
- Section 1: Huoxiang Zhengqi Capsule (see Table 3) (Pill, Water, Oral Liquid)
- I. Drug-Drug Interactions Among Concomitant Medications
- 1. Concomitant medications
- 1.1. The "eighteen clashes" in the combined use of Chinese herbal medicine
- 1.2. Combined use of Western medicines
- 2. Recommendations
- II. Pharmacological Action
- 1. Antispasmodic and analgesic effects
- 2. Immunity-enhancing effects
- 3. Gastrointestinal regulating effects
- 4. Anti-emetic effects
- 5. Anti-inflammatory effects
- 6. Antiviral effects
- 7. Bacteriostatic effects
- 8. Improving water, electrolyte, and metabolic disorders
- 9. Tranquilizing effects
- III. Pharmacist's Notes
- Section 2: Jinhua Qinggan Granule (see Table 3)
- I. Drug-Drug Interactions Among Concomitant Medications
- 1. Concomitant medications
- 1.1. The "eighteen clashes" in the combined use of Chinese herbal medicine.
- 1.2. Combined use of Western medicines
- 2. Recommendations
- II. Pharmacological Action
- 1. Antiviral effects
- 2. Anti-inflammatory effects
- 3. Immunity-enhancing effects
- III. Pharmacist's Notes
- Section 3: Lianhua Qingwen Capsule (Granule) (see Table 3)
- I. Drug-Drug Interactions Among Concomitant Medications
- 1. Issues in concomitant medications
- 2. Recommendations
- II. Pharmacological Action
- 1. Antiviral effects
- 2. Antibacterial effects
- 3. Immune Regulatory effects
- 4. Antipyretic and anti-inflammatory effects
- 5. Other effects
- III. Pharmacist's Notes
- Section 4: Shufeng Jiedu Capsule (see Table 3)
- I. Drug-Drug Interactions Among Concomitant Medications
- II. Pharmacological Action
- 1. Antiviral effects
- 2. Antibacterial effect
- 3. Antipyretic effect
- 4. Anti-inflammatory and immunomodulatory effects
- 5. Analgesic effect
- III. Pharmacist's Notes
- Chapter 5 Guidance on Rational Application of Chinese Patent Medicine during Clinical Treatment Period
- Section 1: Xiyanping Injection (see Table 1)
- I. Administration and Dosage
- II. Drug-Drug Interactions Among Concomitant Medications
- 1. Issues of concomitant medications
- 2. Recommendations
- III. Pharmacological Action
- 1. Antiviral effects
- 2. Antibacterial effects
- 3. Antitussive effects
- 4. Anti-inflammatory and antipyretic effects
- 5. Immunity-enhancing effects
- IV. Pharmacist's Notes
- Section 2: Tanreqing Injection (see Table 1)
- I. Administration and Dosage
- II. Drug-Drug Interactions Among Concomitant Medications
- 1. Issues in concomitant medications
- 2. Recommendations
- III. Pharmacological Action
- 1. Antibacterial and antiviral effects
- 2. Anti-inflammatory and antipyretic effects
- 3. Antitussive effects
- 4. Spasmolysis
- 5. Immunity-enhancing effects
- 6. Apoptosis-promoting effects.
- IV. Pharmacist's Notes
- Section 3: Xuebijing Injection (see Table 1)
- I. Administration and Dosage
- II. Drug-Drug Interactions Among Concomitant Medications
- 1. Issues in mixed administration
- 1.1 The "eighteen clashes" in the combined use of Chinese herbal medicine
- 1.2 Combined use of Western medicines
- 2. Recommendations
- III. Pharmacological Action
- 1. Improving blood coagulation
- 2. Anti-endotoxin effects
- 3. Phagocytosis-improving effects
- 4. Anti-inflammatory effects
- 5. Immune-regulating effects
- 6. Protect and repair damaged organs
- IV. Pharmacist's Notes
- Section 4: Xingnaojing Injection (see Table 1)
- I. Administration and Dosage
- II. Drug-Drug Interactions Among Concomitant Medications
- 1. Issues in concomitant medications
- 2. Recommendations
- III. Pharmacological Action
- 1. Regulating central nervous system
- 2. Brain protection
- 3. Reducing brain edema
- 4. Improving brain microcirculation
- 5. Antiepileptic effects
- 6. Anti-angina effects
- IV. Pharmacist's Notes
- Section 5: Reduning Injection (see Table 1)
- I. Administration and Dosage
- II. Mixed Administration
- 1. Issues in concomitant medications
- 2. Recommendations
- III. Pharmacological Action
- 1. Antipyretic effects
- 2. Antiviral effects
- 3. Antibacterial effects
- 4. Anti-inflammatory effects
- 5. Analgesic effects
- 6. Immunity-enhancing effects
- IV. Pharmacist's Notes
- Section 6: Shengmai Injection (see Table 1)
- I. Administration and Dosage
- II. Drug-Drug Interactions Among Concomitant Medications
- 1. Issues in concomitant medications
- 1.1. The "eighteen clashes" and "nineteen incompatibilities" in the combined use of Chinese herbal medicine
- 1.2. Combined use of Western medicines
- 2. Recommendations
- III. Pharmacological Action
- 1. Immunity-enhancing effects.
- 2. Protecting the heart muscle.